| Quarter | Score |
|---|---|
| 2018-Q1 | 48.0 |
| 2018-Q2 | 54.0 |
| 2018-Q3 | 49.2 |
| 2019-Q2 | 48.8 |
| 2022-Q1 | 49.3 |
| 2022-Q3 | 65.5 |
| 2022-Q4 | 49.3 |
| 2023-Q1 | 49.1 |
| 2023-Q2 | 63.4 |
| 2023-Q3 | 48.0 |
| 2023-Q4 | 65.6 |
| 2024-Q1 | 62.4 |
| 2024-Q2 | 51.6 |
| 2024-Q3 | 51.5 |
| 2024-Q4 | 48.2 |
| 2025-Q1 | 51.6 |
| 2025-Q2 | 81.5 |
| 2025-Q3 | 78.3 |
| 2025-Q4 | 68.2 |
| 2026-Q1 | 51.5 |
| 2026-Q2 | 48.4 |
Stable institutional holding; maintain existing positions
Trading +39.5% above funds' purchase price — elevated pullback risk
1 of 16 tracked funds hold LILAK. Avg conviction: 0.8%. Net adding. First tracked at $6.22 (current +39.5% vs tracked).
Prices are approximate, based on 13F reported values (position value / shares), not actual cost basis. Data covers 16 tracked value-oriented funds. Holdings are reported quarterly with a ~45-day lag. Stock splits may affect share count comparisons. Returns are not annualized.
| Fund | % of Portfolio | Action |
|---|---|---|
| Oaktree Capital | 0.8% | Add |